Skip to main content
logo
Aequus Pharmaceuticals Inc. (TSXV:AQS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Apr 25, 2025, 9:30 AM EST

Aequus Pharmaceuticals Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
-0.330.141.382.712.59
Revenue Growth
-131.31%-89.59%-49.17%4.71%58.81%
Gross Profit
-0.40.080.031.282.67-
Operating Income
-1.76-2.63-3.08-2.71-1.82-1.06
Net Income
-0.66-2.18-2.96-3.21-1.81-1.05
Earnings Per Share
-0.01-0.02-0.02-0.02-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.010.050.220.292.441.72
Total Debt
6.036.615.062.782.182.32
Net Cash (Debt)
-6.02-6.56-4.85-2.490.26-0.6
Net Cash Growth
------
Net Cash Per Share
-0.05-0.05-0.04-0.02--0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-0.12-1.66-2.29-1.95-1.17-0.8
Capital Expenditures
-----0-0.01
Free Cash Flow
-0.12-1.66-2.29-1.95-1.18-0.82
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-24.19%22.57%92.49%98.42%100.00%
Operating Margin
--792.20%-2141.63%-196.56%-67.13%-41.08%
Pretax Margin
--731.14%-2141.11%-232.65%-66.66%-40.32%
Profit Margin
--731.14%-2141.11%-232.65%-66.66%-40.32%
FCF Margin
--498.33%-1596.79%-141.51%-43.33%-31.52%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.723.9923.083.365.625.18